Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Facilities by ADF (ADF) by Steve Moore in ShareProphets
- Buy Tribal Group (TRB) by Hot Stock Rockets in ShareProphets
- Avoid Bunzl (BNZL) by Steve Moore in ShareProphets
- Buy FRP Advisory Group (FRP) by Berenberg
- Buy Beeks Financial Cloud Group (BKS) by Canaccord Genuity
- Buy Harbour Energy (HBR) by Canaccord Genuity
- Avoid The Character Group (CCT) by Steve Moore in ShareProphets
- Buy Rentokil Initial (RTO) by Bank of America
- Neutral Sage Group (SGE) by Goldman Sachs
- Buy 3i Group (III) by UBS
- Buy Boku, Inc (DI) Reg S Cat 3/144A (BOKU) by Jefferies
- Buy Currys (CURY) by Berenberg
- Sector Perform Watches of Switzerland Group (WOSG) by RBC Capital
- Buy Serco Group (SRP) by Citi
- Buy Mondi (MNDI) by William Kay in The Times - Tempus
- Sell Fusion Antibodies (FAB) by Steve Moore in ShareProphets
- Watch SThree (STEM) by Steve Moore in ShareProphets
- Hold RM (RM.) by Hot Stock Rockets in ShareProphets
- Neutral Hochschild Mining (HOC) by UBS
- Buy Reckitt Benckiser Group (RKT) by UBS
Valirx (VAL) Share Price
Health Care Sector
NOTE: This is based on 6 open tips for Valirx (VAL)
| Latest Bid : 0.39p | Latest Ask : 0.41p |
| High Today : 0.43p | Low Today : 0.39p |
| This Years High : 0.88p | This Years Low : 0.22p |
| Volume : 17,813,653 | MKT Cap : £0.53M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Valirx (VAL) Overview
ValiRx accelerates the development of treatments in cancer and women's health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.Valirx (VAL) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2020-06-02 11:40:00 02/06/2020 | -11.45% |
| Sell | Nigel Somerville | Premium Only | 2020-04-02 11:45:00 02/04/2020 | -26,775.00% |
| Buy | Align Research Team | Premium Only | 2018-10-24 09:45:00 24/10/2018 | -73.13% |
| Sell | Nigel Somerville | Premium Only | 2016-04-02 11:00:00 02/04/2016 | 92.22% |
| Sell | Tom Winnifrith | Premium Only | 2015-09-17 15:14:45 17/09/2015 | 93.02% |
Valirx (VAL) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.39p | Latest Ask : 0.41p |
| High Today : 0.43p | Low Today : 0.39p |
| This Years High : 0.88p | This Years Low : 0.22p |
| Volume : 17,813,653 | MKT Cap : £0.53M |
Valirx Overview
ValiRx accelerates the development of treatments in cancer and women's health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Valirx Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2020-06-02 11:40:00 02/06/2020 | -11.45% |
| Sell | Nigel Somerville | Premium Only | 2020-04-02 11:45:00 02/04/2020 | -26,775.00% |
| Buy | Align Research Team | Premium Only | 2018-10-24 09:45:00 24/10/2018 | -73.13% |
| Sell | Nigel Somerville | Premium Only | 2016-04-02 11:00:00 02/04/2016 | 92.22% |
| Sell | Tom Winnifrith | Premium Only | 2015-09-17 15:14:45 17/09/2015 | 93.02% |